Welcome to LookChem.com Sign In|Join Free
  • or
Nitracrine is a pharmaceutical agent characterized by its anti-inflammatory, anti-microbial, and anti-tumor properties, primarily utilized in the treatment of various gynecological and obstetric conditions. It functions by inhibiting abnormal cell growth, reducing inflammation, and facilitating tissue healing, making it a valuable asset in medical interventions for specific health issues.

4533-39-5

Post Buying Request

4533-39-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4533-39-5 Usage

Uses

Used in Gynecological and Obstetric Applications:
Nitracrine is used as a therapeutic agent for managing conditions such as cervical erosion, vaginitis, and endometriosis due to its ability to inhibit the growth and proliferation of abnormal cells, reduce inflammation, and promote healing of damaged tissues.
Used in Pharmaceutical Formulations:
Nitracrine is used as an active ingredient in vaginal suppositories or creams, providing a targeted method of administration for gynecological conditions. Its formulation allows for direct application to the affected area, enhancing the drug's efficacy and minimizing systemic side effects.
It is crucial to administer Nitracrine under the guidance of a healthcare professional and adhere to the prescribed dosage to ensure safety and effectiveness, avoiding potential adverse effects.

Check Digit Verification of cas no

The CAS Registry Mumber 4533-39-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,3 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4533-39:
(6*4)+(5*5)+(4*3)+(3*3)+(2*3)+(1*9)=85
85 % 10 = 5
So 4533-39-5 is a valid CAS Registry Number.
InChI:InChI=1/C18H20N4O2/c1-21(2)12-6-11-19-18-13-7-3-4-8-14(13)20-15-9-5-10-16(17(15)18)22(23)24/h3-5,7-10H,6,11-12H2,1-2H3,(H,19,20)

4533-39-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Nitracrine

1.2 Other means of identification

Product number -
Other names 1-nitro-9-(3-N,N-dimethylaminopropylamino)acridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4533-39-5 SDS

4533-39-5Relevant academic research and scientific papers

Hypoxia-Selective Antitumor Agents. 4. Relationships between Structure, Physicochemical Properties, and Hypoxia-Selective Cytotoxicity for Nitracrine Analogues with Varying Side Chains: The "Iminoacridan Hypothesis"

Denny, William A.,Atwell, Graham J.,Anderson, Robert F.,Wilson, William R.

, p. 1288 - 1295 (2007/10/02)

The nitroacridine derivative nitracrine is a potent hypoxia-selective cytotoxin for mammalian cells in culture.In an attempt to modulate the degree of hypoxia selectivity among this class of compounds, we have studied a series of side-chain analogues of nitracrine.Both the electronic and steric properties of the side chain are shown to be important in determining the hypoxia selectivity of the compounds, by controlling the degree of aminoacridine/iminoacridan tautomerism.Studies with the repair-defective Chinese hamster cell line UV4 indicate that the cytotoxicity ofall the compounds is due to nitro group reduction and subsequent macromolecular adduct formation.However, compounds such as the 9-amino derivative, which exist totally as the aminoacridine tautomer, form much less lethal lesions than the 9-alkylamino derivatives, which exist to varying degrees in the iminoacridan conformation.For the whole set of compounds, the degree of hypoxia-selective cytotoxicity correlates well with the proportion of iminoacridan tautomer present.

Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine

Wilson,Anderson,Denny

, p. 23 - 30 (2007/10/02)

The nitroacridine derivative 9-[[3-(dimethylamino)propyl]amino]-1-nitroacridine (nitracrine) is selectively cytotoxic to hypoxic tumor cells in culture. However, the compound undergoes reductive metabolism too rapidly, with the reduction not being sufficiently inhibited by molecular oxygen in aerobic tissues, for it to demonstrate the same activity in vivo. In a search for derivatives with lower reduction potentials, we have synthesized and evaluated a series of derivatives bearing 4-substituents with a wide range of electronic properties. The one-electron reduction potentials (E(1)) of these compounds, when compared under conditions of equivalent ionization, were highly correlated with σ(p) values. However, at pH 7 the influence of substituent electronic properties was modified by prototropic equilibria, with the basic nature of the acridine limiting the extent to which ring substituent electronic effects can be used to modulate reduction potential of the 1-nitro group. Nevertheless, comparison of the kinetics of the killing of AA8 cells under hypoxia suggests that some metabolic stabilization of the compounds can be achieved by the use of electron-donating substituents, with such compounds retaining the hypoxia-selective toxicity of nitracrine in cell culture. However, the 4-substituted nitracrines show no clear relationship between E(1) and cytotoxic potency, in distinct contrast to simpler nitroheterocycles such as nitroimidazoles.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4533-39-5